Avalus Ultra Post-Approval Study (PAS)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 190 participants.
Also called NCT06506903
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 190 participants
- Sponsor
- Registry
-
NCT06506903
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06506903. Allocation not applicable; no masking; primary purpose treatment. Start 2024-11-20 (actual); primary completion 2026-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Avalus Ultra Post-Approval Study (PAS)
- Condition
- Aortic Valve Disease
- Intervention (Device)
- Medtronic Avalus Ultra
- Lead sponsor
- Medtronic Cardiac Surgery
Record details
- Record id
cardio:ct-nct06506903- Content hash
7d50f3cd29d51e53015e8ce45696e1c2574a86dc373728c66bb75b696db22e94